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a b s t r a c t
Human inﬂuenza viruses predominantly bind α2,6 linked sialic acid (SA) while avian viruses bind α2,3
SA-containing complex glycans. Virulence and tissue tropism of inﬂuenza viruses have been ascribed to
this binding preference. We generated 2009 pandemic H1N1 (pH1N1) viruses with either predominant
α2,3 or α2,6 SA binding and evaluated these viruses in mice and ferrets. The α2,3 pH1N1 virus had
similar virulence in mice and replicated to similar titers in the respiratory tract of mice and ferrets as the
α2,6 and WT pH1N1 viruses. Immunohistochemical analysis determined that all viruses infected similar
cell types in ferret lungs. There is increasing evidence that receptor speciﬁcity of inﬂuenza viruses is
more complex than the binary model of α2,6 and α2,3 SA binding and our data suggest that inﬂuenza
viruses use a wide range of SA moieties to infect host cells.
Published by Elsevier Inc.
Introduction
Inﬂuenza A viruses pose a major public health burden and are
responsible for thousands of deaths each year. Infection by inﬂuenza
viruses is mediated via binding of the viral surface glycoprotein
hemagglutinin (HA) to terminally attached α2,3 or α2,6-linked sialic
acids (SA) on cell surface glycoproteins. Avian inﬂuenza viruses
predominantly bind to glycan receptors terminating in α2,3-linked
SA (henceforth referred to as α2,3 SA) while human-adapted viruses
predominantly bind to glycan receptors terminating in α2,6-linked
SA (henceforth referred to as α2,6 SA) (Matrosovich et al., 2000;
Connor et al., 1994; Rogers and D′Souza, 1989; Rogers and Paulson,
1983). Receptor-binding speciﬁcity is an important determinant of
host-range restriction and transmission of inﬂuenza viruses (Rogers
and Paulson, 1983; Pappas et al., 2010; Tumpey et al., 2007; Couceiro
et al., 1993). The distribution of SA in the human respiratory tract and
duck intestine are thought to dictate the speciﬁcity of viruses
infecting these two species. In humans, the epithelium of the upper
respiratory tract (nasal mucosa and nasopharynx) primarily
expresses α2,6 SA, while the lower respiratory tract (lung) contains
both α2,3 and α2,6 SA (Shinya et al., 2006; van Riel et al., 2006).
In contrast, avian species primarily express α2,3 SA in the cells lining
the gut (Ito et al., 1998). Ferrets, a well-established animal model for
inﬂuenza, have an α2,3 and α2,6 SA distribution similar to humans,
while mice predominantly express α2,3 SA and little α2,6 SA
(van Riel et al., 2006; Ibricevic et al., 2006; Jayaraman et al., 2012).
These observations have dominated the ﬁeld and led to the paradigm
that (1) α2,3 SA binding viruses are limited in their ability to replicate
in humans and ferrets, and when they do so, they lead to severe
lower respiratory tract infection and (2) that α2,3 SA binding viruses
are more virulent and replicate more efﬁciently in mice than α2,6
SA binding viruses.
However, many recent studies provide evidence that this para-
digm is an over-simpliﬁcation. Many avian inﬂuenza viruses are able
to bind both α2,6 and α2,3 SA (Stevens et al., 2006; Wan et al., 2008)
and a change in host range is likely inﬂuenced by association with
complex, physiologically diverse glycans found on airway epithelial
cells (Tharakaraman et al., 2013). Additional glycan analyses found
the presence of both α2,6 and α2,3 SA in the human and ferret
respiratory tract and in different avian species (Jayaraman et al.,
2012; Nicholls et al., 2007; Walther et al., 2013; Kimble et al., 2010).
Additionally, many inﬂuenza viruses with a preference for α2,3 SA,
such as H5N1 viruses, have been recovered from nasal secretions of
naturally infected humans and experimentally infected ferrets
(Suguitan et al., 2006; Subbarao et al., 1998).
In this study we assessed the role of receptor-binding pre-
ference of the viral HA on virulence and tissue tropism of the 2009
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pandemic H1N1 (pH1N1) virus. The pH1N1 virus is known to
predominantly bind to α2,6 SA and replicate well in the upper and
lower respiratory tract of mice and ferrets (Garten et al., 2009; Itoh
et al., 2009; Maines et al., 2009; Munster et al., 2009; Min et al.,
2010). We generated two mutant viruses by engineering four
mutations in the viral HA gene to alter receptor-binding prefer-
ence. One virus contained mutations designed to increase binding
to α2,6 SA (α2,6 pH1N1) and the second virus had mutations
designed to switch binding preference from α2,6 to α2,3 SA (α2,3
pH1N1). We found that the receptor speciﬁcity of the pH1N1 virus
did not inﬂuence virulence in mice or viral replication in the
respiratory tract of mice or ferrets. Additionally, we found that the
WT, α2,6, and α2,3 pH1N1 viruses replicated in similar cell types
in the lungs of ferrets.
Materials and methods
Ethics statement
All animal experiments were done at the NIH, in compliance
with the guidelines of the NIAID/NIH Institutional Animal Care and
Use Committee (ACUC)
Cells and viruses
Madin–Darby canine kidney (MDCK) cells (obtained from
ATCC) were maintained in minimum essential media (MEM) with
10% fetal bovine serum (FBS) and L-glutamine (Gibco). 293T cells
(obtained from ATCC) were maintained in Dulbecco′s MEM with
10% FBS.
The reverse genetics system for generating the 2009 pandemic
H1N1 (pH1N1) virus (A/California/07/2009) was previously described
(Chen et al., 2010). Mutations were engineered using the Stratagene
Site-Directed Mutagenesis kit per the manufacturer′s protocol.
Recombinant viruses generated from reverse genetics plasmids
were rescued in MDCK/293T cell co-culture and propagated for
2 passages in either speciﬁc pathogen free (SPF) embryonated
eggs, for the α2,3 pH1N1 virus, or MDCK cells for the α2,6 pH1N1
virus. The α2,6 pH1N1 did not grow to high titers in eggs and was
propagated in MDCK cells to prevent egg adaptation. The identity
of viruses generated by reverse genetics was conﬁrmed by
genomic sequencing. All experiments were performed using
viruses passaged no more than 3 times in cells or eggs.
Dose dependent glycan binding of wild-type (WT) and mutant
pH1N1 viruses
The receptor speciﬁcity of the WT, α2,3 and α2,6 pH1N1 viruses
were investigated using a selected panel of glycans comprised of
both α2,3 and α2,6 sialylated glycans as previously described
(Jayaraman et al., 2011). Brieﬂy, the wells of streptavidin-coated high
binding capacity 384-well plates (Pierce) were incubated with 50 μL
of 2.4 μM biotinylated glycans overnight at 4 1C. The glycans included
were 3′SLN, 3′SLN-LN, 3′SLN-LN-LN, 6′SLN and 6′SLN-LN. LN corre-
sponds to lactosamine (Galβ1-4GlcNAc) and 3′SLN and 6′SLN,
respectively, correspond to Neu5Acα2-3 and Neu5Acα2-6 linked to
LN. Glycans were obtained from the Consortium of Functional
Glycomics (www.functionalglycomics.org). The viruses (quantiﬁed
in HAU/50 μL) were diluted to 250 μL with 1X PBSþ1% BSA.
A volume of 50 μL diluted virus was added to each of the glycan-
coated wells and incubated overnight at 4 1C. This was followed by
three washes with 1X PBST (1X PBSþ0.1% Tween-20) and three
washes with 1X PBS. The wells were blocked with 1X PBSþ1% BSA
for 2 h at 4 1C followed by incubation with primary antibody (ferret
anti-CA07/09 antisera; 1:200 diluted in 1X PBSþ1% BSA) for 5 h at
4 1C. This was followed by three washes with 1X PBST and three
washes with 1X PBS. Finally the wells were incubated with the
secondary antibody (goat anti-ferret HRP conjugated antibody from
Rockland; 1:200 diluted in 1X PBSþ1% BSA). The wells were washed
with 1X PBST and 1X PBS as before. The binding signals were
determined based on the HRP activity using the Amplex Red
Peroxidase Assay (Invitrogen) according to the manufacturer′s
instructions. Appropriate negative controls included were uncoated
wells (without any glycans) to which just the virus, the antisera and
the antibody were added and glycan-coated wells to which only the
antisera and the antibody were added.
Characterization of viruses in mice
Replication of the viruses in the upper and lower respiratory tract
of 6–8 week old female BALB/c mice was determined as described
(Matsuoka et al., 2009). Brieﬂy, each mouse received 105 median
tissue culture infectious dose (TCID50) of virus in 50 μL intranasally
(IN). Groups of four mice per virus were sacriﬁced on days 1, 3 and 7
post-infection. Nasal turbinates were collected by placing a clamp
around the nose at the angle of the jaw and inverting 1801 to expose
the nasal cavity. Forceps were used to collect the exposed nasal bone
and tissue. The entire lung was collected to measure viral titers in the
lower respiratory tract. Tissues were homogenized and clariﬁed
supernatant was aliquoted and titered on MDCK cells. The 50% tissue
culture infectious dose (TCID50) per gram of tissue was calculated by
the Reed and Muench (1938) method.
The median mouse lethal dose (MLD50) was determined by
administration of serial 10-fold dilutions of the virus and obser-
ving weight loss and survival. In accordance with NIAID ACUC
guidelines, mice were euthanized if they lost more than 25% of
their initial body weight.
Replication of viruses in ferrets
We evaluated the replication kinetics of the viruses in the
respiratory tract of 8–10 week old ferrets as previously described
(Min et al., 2010). All ferrets were screened prior to infection to
ensure that they were naïve to seasonal inﬂuenza A and B, and to
the viruses used in this study. Each ferret was inoculated IN with
106 TCID50 of virus in 500 μL. Tissues were harvested for pathology
and to assess viral titers. Virus titers from tissue samples were
determined on days 1, 3 and 5 post-infection as previously
described (Lakdawala et al., 2011) and expressed in TCID50/g of
tissue. Brieﬂy, tissues were weighed and Leibovitz′s L-15 (L-15,
Invitrogen) was added at 5% (nasal turbinates and trachea) or 10%
(lung) weight per volume (W/V). The nasopharynx was homo-
genized in 1 mL of L-15. Tissues were homogenized and clariﬁed
supernatant was aliquoted and titered on MDCK cells. The 50%
tissue culture infectious dose (TCID50) per gram of tissue was
calculated by the Reed and Muench (1938) method.
Immunohistochemistry
Ferret tissues were stained for inﬂuenza-speciﬁc antigens using
antibodies derived against the whole inﬂuenza virus in goats.
Parafﬁn-embedded microtome sections were incubated at 60 1C
for 30 min and then incubated in xylene and serial dilutions of
ethanol ranging from 100% to 0% in dH2O for 5 min at room
temperature, with a ﬁnal step of 3% H2O2 in methanol for 10 min.
For antigen retrieval, the slides were incubated in sodium citrate
buffer maintained at 95 1C in a water bath for 30 min. Tissue
sections were blocked in PBS-Tween with 1.5% rabbit serum and
stained with 1:300 dilution of anti-inﬂuenza polyclonal antibody
from Abcam (ab20841) and a secondary rabbit anti-goat biotin
conjugated antibody (Vector Labs). Bound antibody was visualized
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using the Vectastain ABC system and DAB stain (Vector Labs) as
per manufacturer′s instructions. Slides were counterstained with
hematoxylin (Vector Labs) and washed in Scott′s Tap water
substitute to enhance the blue stain. Permount was used per
manufacturer′s instructions to mount the slides. A trained veter-
inary pathologist analyzed all slides
Statistics
All viral titer data from replication kinetics experiments are
expressed as mean7standard error and were analyzed using a
Student′s t test, two-way ANOVA, or Mann–Whitney U test in the
graphing software, Prism (GraphPad). p values less than 0.05 are
signiﬁcant.
Results
Generation and rescue of α2,3 and α2,6 SA speciﬁc pH1N1 viruses
Multiple amino acids residues make up the receptor binding
site (RBS) and control receptor speciﬁcity. Since, the HA gene
segment of the pH1N1 virus evolved from the 1918 Spanish
inﬂuenza H1N1 HA (Morens et al., 2009; Xu et al., 2010), for this
study we based changes in the pH1N1 RBS on those already
characterized for the 1918 HA. Two amino acid changes (D187E
and D222G) in the HA RBS of the 1918 H1N1 (A/South Carolina/
1/18 or SC18) HA protein, referred to as the avianized or AV18
virus, were demonstrated to change receptor speciﬁcity from α2,6
to α2,3 SA (Tumpey et al., 2007; Glaser et al., 2005; Srinivasan
et al., 2008). Based on a detailed understanding of molecular
contacts made by SC18 and AV18, respectively, with α2,6 and α2,3
SA receptors, we designed mutations in pH1N1 to mimic the RBS
of SC18 and AV18 (Table 1). The engineered mutations in the RBS
of HA included residues 187, 216, 222 and 224 (H1 numbering),
which make critical molecular contacts with the sialylated glycan
receptors as depicted in the ribbon diagram in Fig. 1A and B
(Jayaraman et al., 2011; Chandrasekaran et al., 2008; Soundararajan
et al., 2009). Residues 187 and 222, as stated above, determine
receptor speciﬁcity of the 1918 HA, while residues 216 and 224 help
stabilize the receptor-binding pocket and have been shown to
enhance SA binding (Jayaraman et al., 2011). Two viruses were
rescued; an α2,6 pH1N1 virus that mimics SC18 at positions 216
and 224 and an α2,3 pH1N1 virus that is similar to AV18 (Table 1). To
construct the α2,6 pH1N1 virus the HA segment was mutated at two
sites, the Isoleucine (I) at 216 (codon ATA) to Alanine (A) (codon GCA)
and Glutamic acid (E) at 224 (codon GAA) to A (Codon GCA) where
the underlined nucleotide indicates the engineered change. The α2,3
pH1N1 virus was created by combining the α2,6 pH1N1 changes
with the following two mutations Aspartic acid (D) at 222 (GAC) to a
Glycine (G) (GGC) and D187 (GAC) to Glutamic acid (E) (GAG)
(Table 1). The receptor speciﬁcity of the engineered pH1N1 viruses
was determined by a dose-dependent glycan binding assay of the
WT, α2,6, and α2,3 pH1N1 viruses (Fig. 1C–E). The WT and α2,6
pH1N1 viruses revealed a strong preference for both long (6′SLN-LN)
and short (6′SLN) α2,6 SA (Fig. 1C and D). In contrast, the α2,3 pH1N1
Table 1
Mutations engineered in the 2009 pH1N1 virus based on 1918 HA sequence.
Pandemic Virus HA amino acid position (H1 numbering)
187 216 222 224
1918 SC18 (α2,6) D A D A
AV18 (α2,3 ) E A G A
2009 WT pH1N1 D I D E
α2,6 pH1N1 D A D A
α2,3 pH1N1 E A G A
Fig. 1. Generation of α2,6 and α2,3 speciﬁc pH1N1 viruses. Ribbon diagrams of the pH1N1 HA receptor binding pocket highlight the critical amino acids in the receptor
binding site of pH1N1 HA that bind with LSTc (α2,6-linked lactoseries tetrasaccharide c) (A) and with LSTa (α2,3-linked lactoseries tetrasaccharide a) (B). Amino acids at
residues 187, 222, and 224 (H1 numbering) that make critical molecular contacts with the sialylated glycan receptor in the receptor-binding pocket of HA are shown. These
residues were mutated to alter the receptor binding speciﬁcity of the pH1N1 HA (see main text for details). Receptor speciﬁcity of wild-type (WT) and mutant pH1N1 viruses
was determined by dose-dependent glycan binding of inactivated whole viruses WT pH1N1 (C), α2,6 pH1N1 (D) and α2,3 pH1N1 (E). The glycans are indicated in the ﬁgure
legend, orange colors represent α2,6 SA and blue colors represent α2,3 SA. Binding is expressed as percentage after normalization with the maximum binding signal.
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virus showed predominant binding to α2,3 SA with some minimal
binding to α2,6 SA (Fig. 1E). Previous studies using this type of glycan
assay have shown that H5N1 viruses also have a low-level of α2,6 SA
binding, similar to the α2,3 pH1N1 virus (Chandrasekaran et al.,
2008).
A single change at residue 222 from D to G in pH1N1 has been
observed in nature and was thought to lead to more severe disease
in infected patients (Liu et al., 2010; Mak et al., 2010). Interestingly,
a single D222G substitution results in a virus with dual binding
speciﬁcity that strongly associates with both α2,6 SA and α2,3
SA binding (Belser et al., 2011; Chutinimitkul et al., 2010). How-
ever, alteration of both D222 and D187 residues in the context of
the other mutations at positions 216 and 224 results in switching
the dominant binding preference of pH1N1 virus from α2,6 SA to
α2,3 SA. Other investigators have also changed the receptor
speciﬁcity of the pH1N1 virus by introducing a single change at
position 226 (Zhang et al., 2012), demonstrating that multiple
amino acids in the RBS can inﬂuence receptor speciﬁcity.
Characterization of WT, α2,3 and α2,6 pH1N1 viruses in mice
To assess whether receptor speciﬁcity of the pH1N1 virus alters
the tissue tropism of the viruses, we tested their ability to replicate
in the upper and lower respiratory tract of mice (Fig. 2A and B).
Replication of WT, α2,6, and α2,3 pH1N1 viruses was determined
in the nasal turbinates and lungs of 4 individual animals on days 1,
3 and 7 post-infection. Despite the predominance of α2,3 SA in
mice (Ibricevic et al., 2006), all three viruses replicated to high
titer in both the nasal turbinates and lungs of all infected animals.
Replication of WT and mutant pH1N1 viruses reached a peak on
day 3 post-infection, with declining titers on day 7 as previously
described for the WT pH1N1 virus (Chen et al., 2011) (Fig. 2A and B).
No signiﬁcant difference was observed among theWT, α2,6, and α2,3
pH1N1 viruses. Thus, receptor speciﬁcity of the pH1N1 virus does not
affect viral replication in the upper or lower respiratory tract of mice.
Previous studies have suggested that virulence of inﬂuenza
viruses in mice correlates with receptor speciﬁcity (Hensley et al.,
2009; Keleta et al., 2008; O′Donnell et al., 2012). We determined
the MLD50 for all three viruses by infecting mice (4 per group)
with serial 10-fold dilutions of virus from a dose of 106 to
103TCID50/50 μL IN and following daily weights and survival. In
accordance with our animal study protocol, mice that lost 425%
of their original body weight were euthanized (Fig. 2C and D). The
MLD50 was similar for all three viruses; 105.5, 104.8 and 104.9 for WT
pH1N1, α2,6 pH1N1 and α2,3 pH1N1, respectively (Fig. 2E). These
results demonstrate that a receptor preference for α2,3 SA does
not alter the virulence of the pH1N1 virus in mice.
Characterization of WT, α2,3 and α2,6 pH1N1 viruses in ferrets
Plant lectins, SNA-I and MAL II that have been used extensively
to characterize the distribution of α2,6 and α2,3 SA, respectively,
in tissue sections from humans, ferrets, and mice (Pappas et al.,
2010; Shinya et al., 2006; Ito et al., 1998; Ibricevic et al., 2006;
Nicholls et al., 2007; Chandrasekaran et al., 2008; Cerna et al.,
2002; Sriwilaijaroen et al., 2011). Staining of ferret tracheal tissue
have shown that airway epithelial cells predominantly express
Fig. 2. Receptor speciﬁcity does not alter replication or virulence in mice. Viral titers in the nasal turbinates (A) and lung (B) were determined from mice infected with WT
(■), α2,6 pH1N1 ( ), and α2,3 pH1N1 ( ). Each point represents an individual animal, bars represent the mean titers among those animals, and the error bars represent the
standard error between animals. Virulence of the WT and mutant pH1N1 viruses was measured in mice by inoculating animals with varying doses of virus (103, 104, 105
TCID50/50 μL). Mice were weighed every day and animals were sacriﬁced if they lost Z25% of their pre-study weight. All animals infected with 104 (C) and 105 (D) TCID50/
50 μL lost weight, but only those in the 105 group were sacriﬁced as indicated by the ( ) symbol. The calculated median mouse lethal dose (MLD50) for each virus was based
upon the survival of mice in the 104 and 105 group (E). The asterisk (*) indicates data previously published in O'Donnell et al., 2012.
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Fig. 3. Receptor speciﬁcity does not alter replication in ferrets. Titers of the WT pH1N1 (■), α2,6 pH1N1 ( ), and α2,3 pH1N1 ( ) from the regions of the ferret respiratory
tract deﬁned on the diagram with dashed circles, include the nasal turbinates (A), nasopharynx (B), trachea (C) and lung (D). Each point represents data from an individual
animal. Mean and standard error are indicated.
Fig. 4. Histopathology of lung sections in ferrets during infection with WT and mutant pH1N1 viruses. Lung lesions of α2,3 pH1N1 infected ferrets were observed in the
alveolar interstitium on day 1 post-infection (A) and in the submucosal glands (SMG) on day 5 post-infection (B). The star (★) indicates SMGs demonstrating signiﬁcant
inﬂammation. Ferrets infected with WT or α2,6 pH1N1 viruses displayed intense peribronchiolar inﬂammation on day 3 post-infection ((C) and (E)) and bronchiolar
hyperplasia on day 5 post-infection ((D) and (F)). Note the marked thickening of the epithelial cell lining and degenerate cell debris in the lumen. A trained veterinary
pathologist analyzed all slides. Scale bars represent 100 μm.
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α2,6 SA while the submucosal glands express both α2,3 and α2,6
SA. Lectin staining of the large airways in the lung demonstrated
that epithelial cells and the submucosal glands preferentially
express α2,6 SA, while goblet cells and the alveolar interstitium
express both α2,3 and α2,6 SA (van Riel et al., 2006; Jayaraman
et al., 2012).
Since ferrets have a differential distribution of SA in the
respiratory tract; we evaluated viral replication kinetics in the
nasal turbinates, nasopharynx, trachea and lungs of ferrets
infected with WT pH1N1, α2,3 pH1N1, or α2,6 pH1N1 viruses
(Fig. 3). In the nasal turbinates, nasopharynx and trachea, all three
viruses replicated to high titers that remained within a 10-fold
range from day 1 to 5 post-infection (Fig. 3A–C). Replication of the
WT and mutant pH1N1 viruses was measured in the lower
respiratory tract of ferrets by determining the viral titer from the
right middle lobe of the ferret lung (Fig. 3D). On day 1 post-
infection, the α2,3 pH1N1 and WT pH1N1 viruses replicated to
high titers while the titer of α2,6 pH1N1 virus was much lower.
However, by day 3 post-infection, replication of the α2,6 pH1N1
virus reached equivalent levels with WT and α2,3 pH1N1 viruses.
Additionally, the peak titer for WT pH1N1 and α2,3 pH1N1 was on
day 1 post-infection while it was day 5 post-infection for α2,6
pH1N1 infected ferrets (Fig. 3D). The difference in replication
kinetics in the ferret respiratory tissues is not related to receptor
speciﬁcity, since the WT and α2,6 pH1N1 viruses have similar
receptor speciﬁcities but differed in their kinetics. Additionally,
WT and α2,3 pH1N1 viruses have distinct receptor preferences but
had similar replication kinetics in the lungs of ferrets at all days
tested. These data suggest that receptor speciﬁcity of pH1N1 virus
does not greatly affect the replication in the ferret respiratory tract
and replication kinetics can vary among virus strains.
We assessed the severity of disease, distribution and kinetics of
pathological lesions in the lungs of ferrets (8 animals/virus).
Ferrets infected with α2,6 pH1N1 virus showed the most severe
pathological changes and while animals infected with WT pH1N1
had histopathological scores that were slightly less severe, the
general degree of inﬂammation was similar between the two
viruses. In contrast, ferrets that received the α2,3 pH1N1 virus
displayed milder disease scores over the course of infection. The
cellular composition of inﬂammatory lesions was similar among
all three viruses and consisted predominantly of neutrophils and
alveolar macrophages (days 1 and 3) that progressed to a more
even admixture of neutrophils, lymphocytes and plasma cells by day
5 post-infection. The distribution of lesions differed among the three
virus groups, ferrets infected with the α2,3 pH1N1 virus predomi-
nantly had inﬂammation associated with the alveolar interstitium on
day 1 post-infection and the submucosal glands (SMG) by day 5 post-
infection (Fig. 4A and B). In contrast, animals infected with either
α2,6 or WT pH1N1 viruses showed airway-centered disease with a
moderate degree of bronchiolar epithelial hyperplasia (Fig. 4C–F) on
day 5 post-infection that likely reﬂects repair of epithelial cell
damage. Bronchiolar hyperplasia was not observed in animals
infected with α2,3 pH1N1 virus. Thus, infection with the α2,6
SA pH1N1 virus leads to more severe histopathological changes in
the lungs than the α2,3 SA pH1N1 virus.
We attempted to identify the cell types infected by the WT and
mutant pH1N1 viruses in ferret lungs on days 1 and 5 post-
infection. With all three viruses, immunohistochemistry showed
that goblet and ciliated cells were positive for viral antigens
(Fig. 5) and viral antigen was also found in the submucosal glands
and alveolar interstitium (Fig. 5). Submucosal glands and ciliated
epithelial cells in the ferret lungs were previously thought to
express only α2,6 SA (Jayaraman et al., 2012), yet the α2,3 pH1N1
virus replicated in these cell types on days 1 and 5. Therefore, our
data demonstrate that receptor-binding preference does not sig-
niﬁcantly alter the tissue tropism of the pH1N1 virus in the ferret
respiratory tract.
Discussion
The previously held paradigm suggests that receptor speciﬁcity,
based on association with α2,6 SA or α2,3 SA, determines replica-
tion and virulence of inﬂuenza viruses. It was believed that α2,6
SA binding viruses replicate more efﬁciently in the upper respira-
tory tract of ferrets while α2,3 SA binding viruses replicate more
efﬁciently in mice and in the lower respiratory tract of ferrets
(Shinya et al., 2006; van Riel et al., 2006; Ito et al., 1998; Ibricevic
et al., 2006). A preference for α2,3 SA was also thought to increase
virulence of inﬂuenza viruses for mice (Hensley et al., 2009; Keleta
et al., 2008; O′Donnell et al., 2012; Brown and Bailly, 1999). In this
study we introduced four amino acid changes into the RBS of the
2009 pH1N1 HA, thereby changing the SA receptor-binding
preference of the 2009 pH1N1 virus from α2,6 SA to α2,3 SA.
Fig. 5. Localization of viral antigen in the lower respiratory tract of ferrets. The animal with the highest viral titer in the lungs from each group sacriﬁced on days 1 and
5 post-infection was analyzed for the location of viral antigen. Lung sections were stained with polyclonal anti-inﬂuenza A antibody and counterstained with hematoxylin.
Representative images were captured for the bronchus, submucosal glands, and alveoli of a ferret infected with WT pH1N1 virus or the mutant viruses. The black arrow (►)
represents ciliated cells stained with inﬂuenza antigen, asterisk (*) mark antigen positive goblet cells, and green arrows ( ) mark antigen positive inﬂammatory cells in the
alveoli. A trained veterinary pathologist analyzed all slides. Scale bars represent 50 μm.
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Characterization of these engineered pH1N1 viruses revealed two
important results. First, there was no difference in the virulence of
the WT, α2,6, and α2,3 pH1N1 viruses in mice. Second, there was
no difference in replication of the three viruses in the upper or
lower respiratory tract of ferrets and mice. This result is consistent
with the previously published ﬁndings on the replication of 1918
pandemic H1N1 viruses, SC18 and AV18, in the ferret respiratory
tract (Tumpey et al., 2007).
Viruses with α2,3 SA speciﬁcity are expected to be more
virulent in mice because the respiratory tract of mice bears α2,3
SA (Hensley et al., 2009; O′Donnell et al., 2012; Brown and Bailly,
1999). However, many properties likely affect virulence of inﬂu-
enza viruses in mice, such as the magnitude of replication,
systemic spread of the virus, and afﬁnity or speciﬁcity for host
receptors. In our study, the α2,3 pH1N1 virus was as virulent as
WT and α2,6 pH1N1 viruses, suggesting that virulence of the
pH1N1 virus in mice is determined by factors other than receptor
speciﬁcity. Our data support the hypothesis that viral replication
may determine virulence in the mouse model, since the WT and
α2,6 pH1N1 viruses replicated similarly to the α2,3 pH1N1 virus in
the upper and lower respiratory tract of mice. Others have shown
that some pH1N1 viruses that were more virulent in mice were
derived as antibody escape mutants (Hensley et al., 2009; O′
Donnell et al., 2012) and resulted in increased receptor avidity
(Hensley et al., 2009). Since the pH1N1 virus does not produce a
systemic infection in mice, viral replication and receptor avidity
rather than binding speciﬁcity likely play a role in determining the
virulence of this virus.
The differential distribution of SA in the human and ferret
respiratory tract is thought to limit the replication of α2,3 SA
dominant inﬂuenza viruses to the lower respiratory tract (Shinya
et al., 2006; van Riel et al., 2006; Jayaraman et al., 2012; Nicholls
et al., 2007; Zhang et al., 2012). However, in this study the α2,3
pH1N1 virus, generated based on the RBS of the 1918 pandemic
SC18 and AV18 viruses (Tumpey et al., 2007), replicated as well as
WT pH1N1 virus in the upper and lower respiratory tract of ferrets
and all viruses replicated in the same cell types in the lungs of
ferrets. In contrast, another recent study characterizing pH1N1
viruses that differed in receptor speciﬁcity found that an α2,3 SA
binding pH1N1 virus (HA/226R) did not replicate well in the lungs
of ferrets (Zhang et al., 2012). Taken together, these results suggest
that the speciﬁc amino acid composition of the HA RBS, rather
than α2,3 and α2,6 SA preference alone, affects viral replication in
the lungs of ferrets and that inﬂuenza viruses likely associate with
a wide range of SA species on cells in the respiratory tract. Recent
advances in glycan array studies have demonstrated the complex-
ity of SA association of inﬂuenza viruses (Stevens et al., 2006;
Walther et al., 2013). One study analyzing human bronchus and lung
tissues demonstrated the presence of a multitude of SA including
both α2,6 and α2,3 linked SA in variable chain lengths (Walther
et al., 2013) suggesting that multiple SA moieties are available for
inﬂuenza viral entry. Therefore, physiological glycan diversity is
more nuanced than characterization of terminal α2,6 and α2,3 SA
linkages alone. This is also evident in the case of the recently
emerged H7N9 inﬂuenza virus, where the binding of this viral HA
to physiological receptors in the human respiratory tract could not
be explained by its binding to a limited set of glycans with α2,6 and
α2,3 SA linkages on prototypic glycan arrays (Tharakaraman et al.,
2013). Further characterization of the SA composition of ferret and
mice respiratory tracts is needed to fully understand the replication
of inﬂuenza viruses in these animal models.
We demonstrate that the α2,3 SA binding pH1N1 virus has
similar virulence in mice and replication in mice and ferrets as the
WT and α2,6 pH1N1 viruses. Previous studies have shown that
association with α2,6 SA is required for respiratory droplet
transmission of inﬂuenza viruses in ferrets (Pappas et al., 2010;
Tumpey et al., 2007; Zhang et al., 2012; Herfst et al., 2012; Imai
et al., 2012; Roberts et al., 2011). Therefore, further characteriza-
tion of the transmissibility of the α2,6 and α2,3 pH1N1 viruses
generated in this study would be of interest.
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